Wikidata

(Q63010660)

English

Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention

clinical trial

In more languages

Statements

title
A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention (English)
0 references
sponsor
Amgen
0 references
country
Austria
0 references
Canada
0 references
Denmark
0 references
Finland
0 references
Germany
0 references
Sweden
0 references
start time
6 September 2017
0 references
end time
16 October 2018
0 references
number of participants
343
0 references
minimum age
18 year
0 references
maximum age
60 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63010660&oldid=2149218911"